Digital Health Acquisition Corp. Signs Material Definitive Agreement
Ticker: VSEEW · Form: 8-K · Filed: Apr 18, 2024 · CIK: 1864531
| Field | Detail |
|---|---|
| Company | Digital Health Acquisition Corp. (VSEEW) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $11.50, $111,111.33, $55,555.67, $300,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement
TL;DR
DHAC just signed a big deal, details TBD.
AI Summary
On April 17, 2024, Digital Health Acquisition Corp. entered into a material definitive agreement. The filing does not specify the nature of the agreement or any involved parties or dollar amounts.
Why It Matters
This filing indicates a significant development for Digital Health Acquisition Corp., suggesting a new business relationship or transaction that could impact its future operations and stock value.
Risk Assessment
Risk Level: medium — The lack of specific details in the filing regarding the material definitive agreement introduces uncertainty and potential risk.
Key Players & Entities
- Digital Health Acquisition Corp. (company) — Registrant
- April 17, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Digital Health Acquisition Corp.?
The filing does not specify the nature of the material definitive agreement.
Who are the other parties involved in this material definitive agreement?
The filing does not disclose the names of the other parties involved in the agreement.
What is the effective date of this material definitive agreement?
The earliest event reported is April 17, 2024, which is the date of the report and likely the effective date or date of entry into the agreement.
Are there any financial terms or dollar amounts associated with this agreement?
The filing does not provide any specific dollar amounts or financial terms related to the agreement.
What is the purpose of this material definitive agreement for Digital Health Acquisition Corp.?
The purpose of the agreement is not detailed in this filing.
Filing Stats: 1,115 words · 4 min read · ~4 pages · Grade level 13.5 · Accepted 2024-04-17 21:54:14
Key Financial Figures
- $0.0001 — ck Market LLC Common Stock, par value $0.0001 per share DHAC The Nasdaq Stock Mar
- $11.50 — of Common Stock at an exercise price of $11.50 DHACW The Nasdaq Stock Market LLC
- $111,111.33 — note having a principal amount equal to $111,111.33 on November 21, 2023 and a senior secur
- $55,555.67 — note having a principal amount equal to $55,555.67 on January 25, 2024 (collectively, the
- $300,000 — missory note in the principal amount of $300,000 on May 5, 2023 (the "Extension Note"),
Filing Documents
- tm2411992d1_8k.htm (8-K) — 37KB
- tm2411992d1_ex2-1.htm (EX-2.1) — 17KB
- tm2411992d1_ex10-1.htm (EX-10.1) — 18KB
- tm2411992d1_ex10-2.htm (EX-10.2) — 26KB
- 0001104659-24-048477.txt ( ) — 341KB
- dhacu-20240417.xsd (EX-101.SCH) — 4KB
- dhacu-20240417_def.xml (EX-101.DEF) — 27KB
- dhacu-20240417_lab.xml (EX-101.LAB) — 37KB
- dhacu-20240417_pre.xml (EX-101.PRE) — 26KB
- tm2411992d1_8k_htm.xml (XML) — 7KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement Third Amended and Restated Business Combination Agreement As previously disclosed in its Current Report on Form 8-Ks filed with the Securities and Exchange Commission (the "SEC") on November 22, 2023 and on February 13, 2024, Digital Health Acquisition Corp. ("DHAC" or the "Company"), DHAC Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of DHAC ("Merger Sub I"), DHAC Merger Sub II, Inc., a Texas corporation and a wholly owned subsidiary of DHAC ("Merger Sub II" and together with Merger Sub I, the "Merger Subs"), VSee Lab, Inc., a Delaware corporation ("VSee"), and iDoc Virtual Telehealth Solutions, Inc., a Texas corporation ("iDoc" and together with DHAC, Merger Sub I, Merger Sub II, VSee and iDoc, the "Parties"), entered into a Third Amended and Restated Business Combination Agreement on November 21, 2023, which was amended by the First Amendment (the "First Amendment") on February 13, 2024 (as amended, the "Business Combination Agreement"). On April 17, 2024, the Parties entered into a Second Amendment (the "Second Amendment") to the Business Combination Agreement, pursuant to which the termination date in the Business Combination Agreement was amended from March 31, 2024 to June 30, 2024. The foregoing description of the Second Amendment does not purport to be complete and is qualified in its entirety by the terms and conditions of the Second Amendment filed as Exhibit 2.1 hereto and incorporated by reference herein. Letter Agreement to Bridge Notes As previously disclosed in the Company's Current Report on Form 8-K filed with the SEC on October 7, 2022, in a private placement transaction on October 5, 2022, the Company, VSee and iDoc entered into a securities purchase agreement (as amended on November 21, 2023) (the "Bridge SPA") with an institutional and accredited investor (the "Bridge Investor"). Pursuant to the Bridge SPA, the Company issued to the Bridge Investor a senior
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit Description 2.1 Second Amendment to the Third Amended and Restated Business Combination Agreement, dated as of April 17, 2024, by and among Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. 10.1 Bridge Letter Agreement dated April 17, 2024 by and among Digital Health Acquisition Corp., VSee Lab, Inc., iDoc Virtual Telehealth Solutions, Inc. and the Bridge Investor 10.2 Extension Letter Agreement dated April 17, 2024 by and between Digital Health Acquisition Corp. and the investor 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 17, 2024 DIGITAL HEALTH ACQUISITION CORP. By: /s/ Scott Wolf Name: Scott Wolf Title: Chief Executive Officer and Chairman